Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 1,206 All time
- Disclosed funding
- $109.5B 703 disclosed amounts
- Median round
- $10.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| MP Modicus PrimeCompany profile Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries | $4.5M | Undisclosed | Healthtech | United States | Investors | |
| O Provides stablecoin yield infrastructure for fintechs and exchanges | $17M | StrategicUndisclosed | Fintech | United Kingdom | Investors | |
| BS Boost SecurityCompany profile Boost Security develops security software for AI-assisted software development. Boost Security develops security software for AI-assisted software development. | $4M | Undisclosed | Cybersecurity | Canada | Investors | |
| 4P 4D PathCompany profile Digital biomarkers designed to predict cancer treatment response from routine biopsy images. Digital biomarkers designed to predict cancer treatment response from routine biopsy images. | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors Undisclosed | |
| E ElevenLabsCompany profile Develops voice AI models and audio synthesis tools for enterprise and consumer applications Develops voice AI models and audio synthesis tools for enterprise and consumer applications | Undisclosed | Undisclosed | AI | United States | Investors | |
| N NavidenceCompany profile Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| R ReducinerCompany profile Converts captured CO₂ into carbon monoxide using renewable electricity for use in industrial systems Converts captured CO₂ into carbon monoxide using renewable electricity for use in industrial systems | €3.6M | Undisclosed | Climate tech | Finland | Investors | |
| A A-CubeCompany profile APIs connecting business software with electronic invoicing, tax reporting and digital document workflows. APIs connecting business software with electronic invoicing, tax reporting and digital document workflows. | €4M | Undisclosed | Fintech | Italy | Investors | |
| GP General ProximityCompany profile Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease | $20M | StrategicUndisclosed | Biotech | United States | Investors | |
| M Decodes cellular networks to advance human health | $20M | Undisclosed | Biotech | Sweden | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1EU Innovation Fund
Epyr, Reverion, H2SITE
18rounds0led - 2NVIDIA
Riverlane, Foresight, Hiverge
14rounds0led - 3Accel
Coast, Origin, Scimplify
12rounds3led - 4Andreessen Horowitz (a16z)
Conway Research, EliseAI, Thatch
12rounds2led - 5Innovate UK
Emerald, Go Eve, Adaptavate
10rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.